120 related articles for article (PubMed ID: 21284945)
1. Proteomic insights into chronic anthracycline cardiotoxicity.
Stěrba M; Popelová O; Lenčo J; Fučíková A; Brčáková E; Mazurová Y; Jirkovský E; Simůnek T; Adamcová M; Mičuda S; Stulík J; Geršl V
J Mol Cell Cardiol; 2011 May; 50(5):849-62. PubMed ID: 21284945
[TBL] [Abstract][Full Text] [Related]
2. Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways.
Jirkovsky E; Popelová O; Kriváková-Stanková P; Vávrová A; Hroch M; Hasková P; Brcáková-Dolezelová E; Micuda S; Adamcová M; Simůnek T; Cervinková Z; Gersl V; Sterba M
J Pharmacol Exp Ther; 2012 Nov; 343(2):468-78. PubMed ID: 22915767
[TBL] [Abstract][Full Text] [Related]
3. Molecular remodeling of left and right ventricular myocardium in chronic anthracycline cardiotoxicity and post-treatment follow up.
Lenčová-Popelová O; Jirkovský E; Mazurová Y; Lenčo J; Adamcová M; Šimůnek T; Geršl V; Štěrba M
PLoS One; 2014; 9(5):e96055. PubMed ID: 24804796
[TBL] [Abstract][Full Text] [Related]
4. Modulation of caveolins, integrins and plasma membrane repair proteins in anthracycline-induced heart failure in rabbits.
Ichikawa Y; Zemljic-Harpf AE; Zhang Z; McKirnan MD; Manso AM; Ross RS; Hammond HK; Patel HH; Roth DM
PLoS One; 2017; 12(5):e0177660. PubMed ID: 28498861
[TBL] [Abstract][Full Text] [Related]
5. Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits.
Jirkovský E; Lenčová-Popelová O; Hroch M; Adamcová M; Mazurová Y; Vávrová J; Mičuda S; Šimůnek T; Geršl V; Štěrba M
Toxicology; 2013 Sep; 311(3):191-204. PubMed ID: 23831762
[TBL] [Abstract][Full Text] [Related]
6. Potential biomarkers for ischemic heart damage identified in mitochondrial proteins by comparative proteomics.
Kim N; Lee Y; Kim H; Joo H; Youm JB; Park WS; Warda M; Cuong DV; Han J
Proteomics; 2006 Feb; 6(4):1237-49. PubMed ID: 16402359
[TBL] [Abstract][Full Text] [Related]
7. Chronic treatment with long acting phosphodiesterase-5 inhibitor tadalafil alters proteomic changes associated with cytoskeletal rearrangement and redox regulation in Type 2 diabetic hearts.
Koka S; Xi L; Kukreja RC
Basic Res Cardiol; 2012 Mar; 107(2):249. PubMed ID: 22311732
[TBL] [Abstract][Full Text] [Related]
8. Experimental determination of diagnostic window of cardiac troponins in the development of chronic anthracycline cardiotoxicity and estimation of its predictive value.
Adamcova M; Lencova-Popelova O; Jirkovsky E; Mazurova Y; Palicka V; Simko F; Gersl V; Sterba M
Int J Cardiol; 2015 Dec; 201():358-67. PubMed ID: 26310978
[TBL] [Abstract][Full Text] [Related]
9. Alterations of mitochondrial enzymes contribute to cardiac hypertrophy before hypertension development in spontaneously hypertensive rats.
Meng C; Jin X; Xia L; Shen SM; Wang XL; Cai J; Chen GQ; Wang LS; Fang NY
J Proteome Res; 2009 May; 8(5):2463-75. PubMed ID: 19265432
[TBL] [Abstract][Full Text] [Related]
10. Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo.
Popelová O; Sterba M; Simůnek T; Mazurová Y; Guncová I; Hroch M; Adamcová M; Gersl V
J Pharmacol Exp Ther; 2008 Jul; 326(1):259-69. PubMed ID: 18434588
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of anthracycline-induced cardiotoxicity and its prevention.
Horenstein MS; Vander Heide RS; L'Ecuyer TJ
Mol Genet Metab; 2000; 71(1-2):436-44. PubMed ID: 11001837
[TBL] [Abstract][Full Text] [Related]
12. Persistent regional downregulation in mitochondrial enzymes and upregulation of stress proteins in swine with chronic hibernating myocardium.
Page B; Young R; Iyer V; Suzuki G; Lis M; Korotchkina L; Patel MS; Blumenthal KM; Fallavollita JA; Canty JM
Circ Res; 2008 Jan; 102(1):103-12. PubMed ID: 17967786
[TBL] [Abstract][Full Text] [Related]
13. Rabbit model for in vivo study of anthracycline-induced heart failure and for the evaluation of protective agents.
Simůnek T; Klimtová I; Kaplanová J; Mazurová Y; Adamcová M; Sterba M; Hrdina R; Gersl V
Eur J Heart Fail; 2004 Jun; 6(4):377-87. PubMed ID: 15182761
[TBL] [Abstract][Full Text] [Related]
14. Study of daunorubicin cardiotoxicity prevention with pyridoxal isonicotinoyl hydrazone in rabbits.
Simůnek T; Klimtová I; Kaplanová J; Sterba M; Mazurová Y; Adamcová M; Hrdina R; Gersl V; Ponka P
Pharmacol Res; 2005 Mar; 51(3):223-31. PubMed ID: 15661572
[TBL] [Abstract][Full Text] [Related]
15. Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings?
Lenčová-Popelová O; Jansová H; Jirkovský E; Bureš J; Jirkovská-Vávrová A; Mazurová Y; Reimerová P; Vostatková L; Adamcová M; Hroch M; Pokorná Z; Kovaříková P; Šimůnek T; Štěrba M
Toxicology; 2016 Nov; 372():52-63. PubMed ID: 27816693
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of left ventricular tissues following intermittent myocardial ischemia during coronary collateralization in rabbits.
Gu J; Wang Y; Li J; Wang J; Jin T
Int J Cardiol; 2009 Jan; 131(3):326-35. PubMed ID: 18207584
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis reveals significant alternations of cardiac small heat shock protein expression in congestive heart failure.
Dohke T; Wada A; Isono T; Fujii M; Yamamoto T; Tsutamoto T; Horie M
J Card Fail; 2006 Feb; 12(1):77-84. PubMed ID: 16500585
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of left ventricular remodeling in an experimental model of heart failure.
Cieniewski-Bernard C; Mulder P; Henry JP; Drobecq H; Dubois E; Pottiez G; Thuillez C; Amouyel P; Richard V; Pinet F
J Proteome Res; 2008 Nov; 7(11):5004-16. PubMed ID: 18922030
[TBL] [Abstract][Full Text] [Related]
19. Proteomic and metabolomic analysis of atrial profibrillatory remodelling in congestive heart failure.
De Souza AI; Cardin S; Wait R; Chung YL; Vijayakumar M; Maguy A; Camm AJ; Nattel S
J Mol Cell Cardiol; 2010 Nov; 49(5):851-63. PubMed ID: 20655923
[TBL] [Abstract][Full Text] [Related]
20. Exposure to anthracyclines during childhood causes cardiac injury.
Lipshultz SE
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
